Autolus Therapeutics (AUTL) Assets Average (2017 - 2025)

Autolus Therapeutics (AUTL) has 9 years of Assets Average data on file, last reported at $625.5 million in Q4 2025.

• For the quarter ending Q4 2025, Assets Average fell 22.31% year-over-year to $625.5 million; the trailing twelve-month figure through Dec 2025 stood at $625.5 million (down 22.31% YoY), and the FY2025 full-year result was $685.9 million, up 18.45% from the prior year.
• Assets Average for Q4 2025 stood at $625.5 million, down from $691.5 million in the prior quarter.
• Across five years, Assets Average topped out at $877.5 million in Q2 2024 and bottomed at $288.9 million in Q3 2022.
• The 5-year median for Assets Average is $442.0 million (2023), against an average of $522.2 million.
• The widest annual swing landed in 2024, when Assets Average soared 106.05%; it then retreated 22.31% in 2025.
• A 5-year view of Assets Average shows it stood at $351.1 million in 2021, then grew by 7.39% to $377.1 million in 2022, then grew by 3.63% to $390.7 million in 2023, then surged by 106.05% to $805.1 million in 2024, then dropped by 22.31% to $625.5 million in 2025.
• The last three Assets Average figures came in at $625.5 million (Q4 2025), $691.5 million (Q3 2025), and $733.7 million (Q2 2025), per Business Quant data.

Peer Comparison